Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

12.91
Delayed Data
As of Mar 23
 +0.05 / +0.39%
Today’s Change
8.67
Today|||52-Week Range
14.15
+20.65%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close12.86
Today’s open12.88
Day’s range12.83 - 13.18
Volume2,400,920
Average volume (3 months)922,463
Market cap$1.4B
Dividend yield7.75%
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+132.55%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio24.4
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+0.52+3.65%
SUPNSupernus Pharmaceuti...-0.05-0.18%
LXRXLexicon Pharmaceutic...-0.07-0.49%
AERIAerie Pharmaceutical...+0.20+0.44%
Data as of 4:01pm ET, 03/23/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs